123 related articles for article (PubMed ID: 38215603)
1. Enhancing oral delivery and anticancer efficacy of 7-ethyl-10-hydroxycamptothecin through self-assembled micelles of deoxycholic acid grafted N'-nonyl-trimethyl chitosan.
Huang J; Tang X; Yang Z; Chen J; Wang K; Shi C; Liu Z; Wu M; Du Q
Colloids Surf B Biointerfaces; 2024 Feb; 234():113736. PubMed ID: 38215603
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity.
Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G
Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251
[TBL] [Abstract][Full Text] [Related]
3. N-Deoxycholic acid-N,O-hydroxyethyl Chitosan with a Sulfhydryl Modification To Enhance the Oral Absorptive Efficiency of Paclitaxel.
Yu Y; Huo M; Fu Y; Xu W; Cai H; Yao L; Chen Q; Mu Y; Zhou J; Yin T
Mol Pharm; 2017 Dec; 14(12):4539-4550. PubMed ID: 29058910
[TBL] [Abstract][Full Text] [Related]
4. Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin.
Si J; Zhao X; Gao S; Huang D; Sui M
Int J Pharm; 2019 Sep; 568():118499. PubMed ID: 31299338
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N, O-hydroxyethyl chitosan micellar system.
Li H; Huo M; Zhou J; Dai Y; Deng Y; Shi X; Masoud J
J Pharm Sci; 2010 Nov; 99(11):4543-53. PubMed ID: 20845453
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled micelles based on N-octyl-N'-phthalyl-O-phosphoryl chitosan derivative as an effective oral carrier of paclitaxel.
Qu G; Hou S; Qu D; Tian C; Zhu J; Xue L; Ju C; Zhang C
Carbohydr Polym; 2019 Mar; 207():428-439. PubMed ID: 30600025
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of camptothecin-loaded multifunctional chitosan-based micelles is effective in reduce colorectal cancer.
Almeida A; Castro F; Resende C; Lúcio M; Schwartz S; Sarmento B
J Control Release; 2022 Sep; 349():731-743. PubMed ID: 35905784
[TBL] [Abstract][Full Text] [Related]
8. Research Progress of SN38 Drug Delivery System in Cancer Treatment.
Qi QR; Tian H; Yue BS; Zhai BT; Zhao F
Int J Nanomedicine; 2024; 19():945-964. PubMed ID: 38293612
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel polymeric nanoparticles (methoxy-polyethylene glycol-chitosan/hyaluronic acid) containing 7-ethyl-10-hydroxycamptothecin for colon cancer therapy:
Sharifi F; Jahangiri M; Ebrahimnejad P
Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):367-380. PubMed ID: 33851564
[TBL] [Abstract][Full Text] [Related]
10. Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives.
Zhang C; Ding Y; Yu LL; Ping Q
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):192-9. PubMed ID: 17223019
[TBL] [Abstract][Full Text] [Related]
11. A ROS-response hyaluronic acid-coated/chitosan polymer prodrug for enhanced tumour targeting efficacy of SN38.
Qin J; Sun M; Zhen Y; Li J; Wang D
J Drug Target; 2023 Jul; 31(6):623-633. PubMed ID: 37216422
[TBL] [Abstract][Full Text] [Related]
12. Multi-functional chitosan polymeric micelles as oral paclitaxel delivery systems for enhanced bioavailability and anti-tumor efficacy.
Chen T; Tu L; Wang G; Qi N; Wu W; Zhang W; Feng J
Int J Pharm; 2020 Mar; 578():119105. PubMed ID: 32018019
[TBL] [Abstract][Full Text] [Related]
13. CD133-targeted delivery of self-assembled PEGylated carboxymethylcellulose-SN38 nanoparticles to colorectal cancer.
Alibolandi M; Abnous K; Anvari S; Mohammadi M; Ramezani M; Taghdisi SM
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1159-1169. PubMed ID: 29519158
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Zhu H; Cao J; Cui S; Qian Z; Gu Y
J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
[TBL] [Abstract][Full Text] [Related]
15. Sterically Stabilized Polyionic Complex Nanogels of Chitosan Lysate and PEG-b-Polyglutamic Acid Copolymer for the Delivery of Irinotecan Active Metabolite (SN-38).
Salmanpour M; Saeed-Vaghefi M; Abolmaali SS; Tamaddon AM
Curr Drug Deliv; 2021; 18(6):741-752. PubMed ID: 33155910
[TBL] [Abstract][Full Text] [Related]
16. N-mercapto acetyl-N'-octyl-O, N″-glycol chitosan as an efficiency oral delivery system of paclitaxel.
Huo M; Fu Y; Liu Y; Chen Q; Mu Y; Zhou J; Li L; Xu W; Yin T
Carbohydr Polym; 2018 Feb; 181():477-488. PubMed ID: 29253998
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled nanomicelles of damnacanthal-loaded amphiphilic modified chitosan: Preparation, characterization and cytotoxicity study.
Sukamporn P; Baek SJ; Gritsanapan W; Chirachanchai S; Nualsanit T; Rojanapanthu P
Mater Sci Eng C Mater Biol Appl; 2017 Aug; 77():1068-1077. PubMed ID: 28531980
[TBL] [Abstract][Full Text] [Related]
18. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
Wang X; Chen Y; Dahmani FZ; Yin L; Zhou J; Yao J
Biomaterials; 2014 Aug; 35(26):7654-65. PubMed ID: 24927684
[TBL] [Abstract][Full Text] [Related]
19. Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel.
Li L; Liang N; Wang D; Yan P; Kawashima Y; Cui F; Sun S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322014
[TBL] [Abstract][Full Text] [Related]
20. A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer.
Huang Q; Liu X; Wang H; Liu X; Zhang Q; Li K; Chen Y; Zhu Q; Shen Y; Sui M
Acta Biomater; 2022 Jan; 137():262-275. PubMed ID: 34718178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
